Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces Enterprise 3D Modeling Deal With AI Revenue Driving Growth (click to learn more)
Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revelation Biosciences Inc
REVB
Healthcare
Biotechnology
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its...
product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:REVB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 4:40pm
REVB Releases Positive Test Results—Potential Catalyst
https://beyondspx.com/2024/08/01/revb-releases-positive-test-results-potential-catalyst/
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 24, 2024 10:47am
RE:REVB.....sold all into the opening strength
The reason I sold was that there is a financing in the makings.....however.....it's not effective....YET ; ) https://www.sec.gov/Archives/edgar/data/1810560/000095017024075011/2021_equity_plan
...more
Graphite One and Lucid Enter into Second Non-Binding Supply Agreement
posted Jun 12, 2025 9:00am by
Graphite One Inc.
-
|
Graphite One CEO, Anthony Huston: "This Agreement makes Graphite One the only company to date to provide both natural and synthetic graphite materials required for battery anodes to a U.S. EV company." ...read more
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 24, 2024 9:39am
REVB.....sold all into the opening strength
Cha Ching!!!!
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 24, 2024 9:07am
REVB....News Release
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity 2024-06
...more
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 13, 2024 9:31am
REVB....NR....On watch
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini 2024-06-13 06:21 ET - News Release -Top-line data forthcoming- Clinical Study of Gemini 024-06
...more
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 07, 2024 3:35pm
RE:RE:REVB.....What a Revelation....sub $2
What did I tell everyone......the low was ~ $1.61.......did anyone buy that dip? Where is it today......I'd say it's going to high close over $2.50....very low volume therefore this is not
...more
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 15, 2024 1:13pm
RE:REVB.....What a Revelation....sub $2
And just to keep the REVB audience up to date......the next meeting is in about a month....so watch this bleed til then How low can this go.......Those Ruthless Directors want cheap options.....which
...more
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 15, 2024 11:34am
REVB.....What a Revelation....sub $2
Whodda thunk......slow bleed right back to the "Woodshed for another butt whoopin"
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 22, 2024 4:15pm
New Press Release - Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended December 31, 2023 financial...
read article.
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 21, 2024 10:05am
RE:REVB....boring as Fack !
Reason to leave u ask? Because this can never hold a gain....example....this a.m!
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 20, 2024 12:20pm
REVB....boring as Fack !
Moved to greener pastures
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 12:25pm
REVB....would you believe me if I told u......
this is going to rip ? $2.46
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 13, 2024 9:09am
New Press Release - Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”) a clinical-stage life...
read article.
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 13, 2024 9:05am
RE:REVB.....still on watch
Worth a repeat ; )
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 12, 2024 9:08am
New Press Release - Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Despite turbulent markets this logistics company continues to grow
Merger Announced to Create a Leading Yukon Copper-Gold Exploration and Development Company
Graphite One and Lucid Enter into Second Non-Binding Supply Agreement
Graphite Creek Project Approved for FAST-41 Federal Permitting Dashboard
Mullen Group acquires company expected to generate annualized revenues of $300 million